CARLTON BALDWIN: Open Payments
NPI 1487850103 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,780 in 106 payments from 17 companies in 2025. Trend: 2023 $1,364 · 2024 $1,378 · 2025 $1,780
Food & beverage: $1,780
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $337 |
| Novo Nordisk Inc | 18 | $305 |
| Lilly USA, LLC | 17 | $224 |
| ABBVIE INC. | 14 | $211 |
| GlaxoSmithKline, LLC. | 13 | $192 |
| Merck Sharp & Dohme LLC | 10 | $137 |
| Amgen Inc. | 4 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| Exact Sciences Corporation | 3 | $54 |
| Vanda Pharmaceuticals Inc. | 2 | $51 |
Products named: AIRSUPRA, Wegovy, MOUNJARO, QULIPTA, VERQUVO, TRELEGY ELLIPTA, SHINGRIX, FARXIGA.
Industry payments across AL — which companies pay providers there.
